All Stories

  1. Bioinspired soft nanovesicles for site‐selective cancer imaging and targeted therapies
  2. Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019
  3. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
  4. Prodrug Polymeric Nanoconjugates Encapsulating Gold Nanoparticles for Enhanced X‐Ray Radiation Therapy in Breast Cancer
  5. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  6. Nanomedicine-based strategies to target and modulate the tumor microenvironment
  7. Child Mortality Trends and Targets: GBD 2019 Findings
  8. Facts and Figures on Materials Science and Nanotechnology Progress and Investment
  9. Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression
  10. CRISPR Systems for COVID-19 Diagnosis
  11. Controlled delivery of gold nanoparticle-coupled miRNA therapeuticsviaan injectable self-healing hydrogel
  12. Revisiting gene delivery to the brain: silencing and editing
  13. Biomimetic cancer cell membrane-coated nanosystems as next-generation cancer therapies
  14. Why Go NANO on COVID-19 Pandemic?
  15. Above and Beyond Cancer Therapy: Translating Biomaterials into the Clinic
  16. Tetrazine Carbon Nanotubes for Pretargeted In Vivo “Click‐to‐Release” Bioorthogonal Tumour Imaging
  17. Nanotechnology-based disinfectants and sensors for SARS-CoV-2
  18. Liposomal nanotheranostics for multimode targeted in vivo bioimaging and near‐infrared light mediated cancer therapy
  19. Platinum-Triggered Bond-Cleavage of Pentynoyl Amide and N-Propargyl Handles for Drug-Activation
  20. Composite Hydrogels: Prolonged Local In Vivo Delivery of Stimuli‐Responsive Nanogels That Rapidly Release Doxorubicin in Triple‐Negative Breast Cancer Cells (Adv. Healthcare Mater. 4/2020)
  21. Prolonged Local In Vivo Delivery of Stimuli‐Responsive Nanogels That Rapidly Release Doxorubicin in Triple‐Negative Breast Cancer Cells
  22. Oral pH sensitive GNS@ab nanoprobes for targeted therapy of Helicobacter pylori without disturbance gut microbiome
  23. Gastric Parietal Cell and Intestinal Goblet Cell Secretion: a Novel Cell-Mediated In Vivo Metal Nanoparticle Metabolic Pathway Enhanced with Diarrhea Via Chinese Herbs
  24. Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression
  25. Cisplatin-Triggered Bioorthogonal Decaging of Amide Bonds for Targeted-Drug Activation in vivo
  26. Biopolymers for Antitumor Implantable Drug Delivery Systems: Recent Advances and Future Outlook
  27. Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma
  28. Nanoparticle-antagomiR based targeting of miR-31 to induce osterix and osteocalcin expression in mesenchymal stem cells
  29. Displaying biofunctionality on materials through templated self-assembly
  30. Handbook of Nanomaterials for Cancer Theranostics
  31. Fullerene: biomedical engineers get to revisit an old friend
  32. Smart NIR linear and nonlinear optical nanomaterials for cancer theranostics: Prospects in photomedicine
  33. Plasmonic gold nanoparticles for detection of fungi and human cutaneous fungal infections
  34. Designing Hydrogels for On-Demand Therapy
  35. 3D hydrogel scaffold doped with 2D graphene materials for biosensors and bioelectronics
  36. Empowering the Potential of Cell-Penetrating Peptides for Targeted Intracellular Delivery via Molecular Self-Assembly
  37. Gold nanostars for efficient in vitro and in vivo real-time SERS detection and drug delivery via plasmonic-tunable Raman/FTIR imaging
  38. Local microRNA delivery targets Palladin and prevents metastatic breast cancer
  39. Chiral Antioxidant-based Gold Nanoclusters Reprogram DNA Epigenetic Patterns
  40. Revisiting the ‘One Material Fits All’ Rule for Cancer Nanotherapy
  41. Revisiting the classification of NIR-absorbing/emitting nanomaterials for in vivo bioapplications
  42. Biomaterials for Abrogating Metastasis: Bridging the Gap between Basic and Translational Research
  43. Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model
  44. Gold nanoprisms as a hybrid in vivo cancer theranostic platform for in situ photoacoustic imaging, angiography, and localized hyperthermia
  45. Dual-Color Emissive Upconversion Nanocapsules for Differential Cancer Bioimaging In Vivo
  46. Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
  47. Dual-sensitive hydrogel composite for local release and selective uptake of chemotherapy for the treatment of breast cancer
  48. RNAi nanomaterials targeting immune cells as an anti-tumor therapy: the missing link in cancer treatment?
  49. Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment
  50. The Golden Age in Cancer Nanobiotechnology: Quo Vadis?
  51. Investigating the role of shape on the biological impact of gold nanoparticles in vitro
  52. Significance of the balance between intracellular glutathione and polyethylene glycol for successful release of small interfering RNA from gold nanoparticles
  53. Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects
  54. 15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeutics
  55. Personalized Medicine: Personalizing Biomaterials for Precision Nanomedicine Considering the Local Tissue Microenvironment (Adv. Healthcare Mater. 11/2015)
  56. Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis
  57. Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi-Peptide Nanoparticles to Tumor-Associated Macrophages and Cancer Cells
  58. POxylated Polyurea Dendrimers: Smart Core-Shell Vectors with IC50Lowering Capacity
  59. Personalizing Biomaterials for Precision Nanomedicine Considering the Local Tissue Microenvironment
  60. The next generation of smart gold nanobeacons: nanotheranostics is ready for prime time
  61. Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance
  62. Are RNAi and miRNA therapeutics truly dead?
  63. RNAi-based glyconanoparticles trigger apoptotic pathways for in vitro and in vivo enhanced cancer-cell killing
  64. Target-responsive DNA/RNA nanomaterials for microRNA sensing and inhibition: The jack-of-all-trades in cancer nanotheranostics?
  65. A promising road with challenges: where are gold nanoparticles in translational research?
  66. Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine
  67. Antibody–drug gold nanoantennas with Raman spectroscopic fingerprints for in vivo tumour theranostics
  68. Polyurea dendrimer for efficient cytosolic siRNA delivery
  69. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models
  70. Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis
  71. Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events
  72. Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?
  73. Modification of plasmid DNA topology by ‘histone-mimetic’ gold nanoparticles
  74. Design of Multifunctional Gold Nanoparticles for In Vitro and In Vivo Gene Silencing
  75. Genotoxic effects of occupational exposure to lead and influence of polymorphisms in genes involved in lead toxicokinetics and in DNA repair
  76. Gold-nanobeacons for real-time monitoring of RNA synthesis
  77. Effect of PEG biofunctional spacers and TAT peptide on dsRNA loading on gold nanoparticles
  78. Noble Metal Nanoparticles for Biosensing Applications
  79. Nanophotonics for Molecular Diagnostics and Therapy Applications
  80. Alloy metal nanoparticles for multicolor cancer diagnostics
  81. In vitro transcription and translation inhibition via DNA functionalized gold nanoparticles
  82. Use of cyclodextrins as scavengers of inhibitory photo-products in light controlled in vitro synthesis of RNA
  83. RNA quantification using gold nanoprobes - application to cancer diagnostics
  84. Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study